Evidence-Based Medicine Guidelines
Chemotherapy for hormone-refractory prostate cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Chemotherapy for Hormone-refractory Prostate Cancer." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450826/all/_________Chemotherapy_for_hormone_refractory_prostate_cancer______.
Chemotherapy for hormone-refractory prostate cancer. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/450826/all/_________Chemotherapy_for_hormone_refractory_prostate_cancer______. Accessed March 23, 2025.
Chemotherapy for hormone-refractory prostate cancer. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/450826/all/_________Chemotherapy_for_hormone_refractory_prostate_cancer______
Chemotherapy for Hormone-refractory Prostate Cancer [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450826/all/_________Chemotherapy_for_hormone_refractory_prostate_cancer______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Chemotherapy for hormone-refractory prostate cancer
ID - 450826
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450826/all/_________Chemotherapy_for_hormone_refractory_prostate_cancer______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
